SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales for the September 2021 quarter moved down -31.01% to Rs. 3304.00 millions as compared to Rs. 4789.00 millions during the year ago period.The Company's Net profit for the September 2021 quarter have declined marginally to Rs. 536.00  millions as against Rs. 709.00 millions reported during the corresponding quarter ended.The company reported a degrowth in operating Profit to 897.00 millions from 1176.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 3304.00 4789.00 -31.01 7242.00 10111.00 -28.38 16535.00 17902.00 -7.64
Other Income 403.00 272.00 48.16 526.00 471.00 11.68 1011.00 1238.00 -18.34
PBIDT 897.00 1176.00 -23.72 2156.00 3101.00 -30.47 5187.00 7018.00 -26.09
Interest 32.00 27.00 18.52 50.00 60.00 -16.67 113.00 206.00 -45.15
PBDT 865.00 1149.00 -24.72 2106.00 3041.00 -30.75 5074.00 6812.00 -25.51
Depreciation 342.00 284.00 20.42 673.00 560.00 20.18 1152.00 981.00 17.43
PBT 523.00 865.00 -39.54 1433.00 2481.00 -42.24 3922.00 5831.00 -32.74
TAX -13.00 156.00 -108.33 145.00 505.00 -71.29 827.00 1086.00 -23.85
Deferred Tax -113.00 -50.00 126.00 -110.00 -115.00 -4.35 -106.00 -205.00 -48.29
PAT 536.00 709.00 -24.40 1288.00 1976.00 -34.82 3095.00 4745.00 -34.77
Equity 365.00 364.00 0.27 365.00 364.00 0.27 365.00 364.00 0.27
PBIDTM(%) 27.15 24.56 10.56 29.77 30.67 -2.93 31.37 39.20 -19.98

Natco Pharma Share Price

1102.80 -16.15 (-1.44%)
20-Apr-2026 14:42 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.90
Dr. Reddys Lab 1233.00
Cipla 1230.95
Zydus Lifesciences 937.65
Lupin 2326.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×